Form 8-K · Current Report · Filed 2024-12-11
West Pharmaceutical Services Appoints Janet Haugen to Board of Directors
West Pharmaceutical Services, Inc. announced on December 9, 2024, the election of Janet Haugen to its Board of Directors. Ms. Haugen, with extensive experience as former CFO of Unisys Corporation, brings significant expertise in finance and technology to West's Board, which now comprises 12 members. Her appointment was officially disclosed via press release on December 11, 2024.
- Filer
- West Pharmaceutical Services Inc. WST · NYSE
- Filed
- Accession
- 0000105770-24-000084
- CIK
- 0000105770
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$319.27
Next session
+3.9%
Since filing
+6.8%
Latest close
$340.96
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from WST reporting the same item, with the next session's move:
Exhibits (1)
About West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.
Never miss another WST filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.